| UniProt ID | LYPL1_HUMAN | |
|---|---|---|
| UniProt AC | Q5VWZ2 | |
| Protein Name | Lysophospholipase-like protein 1 | |
| Gene Name | LYPLAL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 237 | |
| Subcellular Localization |
Isoform 1: Cytoplasm, cytosol . Isoform 2: Cytoplasm, cytosol . |
|
| Protein Description | Has depalmitoylating activity toward KCNMA1. Does not exhibit phospholipase nor triacylglycerol lipase activity, able to hydrolyze only short chain substrates due to its shallow active site.. | |
| Protein Sequence | MAAASGSVLQRCIVSPAGRHSASLIFLHGSGDSGQGLRMWIKQVLNQDLTFQHIKIIYPTAPPRSYTPMKGGISNVWFDRFKITNDCPEHLESIDVMCQVLTDLIDEEVKSGIKKNRILIGGFSMGGCMAIHLAYRNHQDVAGVFALSSFLNKASAVYQALQKSNGVLPELFQCHGTADELVLHSWAEETNSMLKSLGVTTKFHSFPNVYHELSKTELDILKLWILTKLPGEMEKQK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAASGSVL ------CCCCCCCHH | 16.25 | 25944712 | |
| 7 | Phosphorylation | -MAAASGSVLQRCIV -CCCCCCCHHHHHHC | 19.70 | 28857561 | |
| 15 | Phosphorylation | VLQRCIVSPAGRHSA HHHHHHCCCCCCCEE | 6.79 | 21406692 | |
| 17 | Ubiquitination | QRCIVSPAGRHSASL HHHHCCCCCCCEEEE | 21.83 | 21890473 | |
| 21 | Phosphorylation | VSPAGRHSASLIFLH CCCCCCCEEEEEEEE | 20.42 | 27080861 | |
| 23 | Phosphorylation | PAGRHSASLIFLHGS CCCCCEEEEEEEECC | 25.64 | 27080861 | |
| 30 | Phosphorylation | SLIFLHGSGDSGQGL EEEEEECCCCCCHHH | 28.78 | 21406692 | |
| 32 | Ubiquitination | IFLHGSGDSGQGLRM EEEECCCCCCHHHHH | 51.82 | 21890473 | |
| 33 | Phosphorylation | FLHGSGDSGQGLRMW EEECCCCCCHHHHHH | 36.22 | 21406692 | |
| 41 | Ubiquitination | GQGLRMWIKQVLNQD CHHHHHHHHHHHCCC | 1.31 | 21890473 | |
| 55 (in isoform 1) | Ubiquitination | - | 22.41 | 21890473 | |
| 55 | Ubiquitination | DLTFQHIKIIYPTAP CCCEEEEEEEECCCC | 22.41 | 21890473 | |
| 55 (in isoform 2) | Ubiquitination | - | 22.41 | 21890473 | |
| 55 | Ubiquitination | DLTFQHIKIIYPTAP CCCEEEEEEEECCCC | 22.41 | 21890473 | |
| 66 | Phosphorylation | PTAPPRSYTPMKGGI CCCCCCCCCCCCCCC | 19.01 | - | |
| 70 | Ubiquitination | PRSYTPMKGGISNVW CCCCCCCCCCCCEEE | 56.01 | 21890473 | |
| 70 | Ubiquitination | PRSYTPMKGGISNVW CCCCCCCCCCCCEEE | 56.01 | 21890473 | |
| 70 (in isoform 1) | Ubiquitination | - | 56.01 | 21890473 | |
| 74 | Phosphorylation | TPMKGGISNVWFDRF CCCCCCCCEEEECEE | 28.71 | 28857561 | |
| 79 | Ubiquitination | GISNVWFDRFKITND CCCEEEECEEEEECC | 39.12 | 21890473 | |
| 124 | Phosphorylation | RILIGGFSMGGCMAI CEEEECCCHHHHHHH | 21.57 | - | |
| 151 | Ubiquitination | VFALSSFLNKASAVY HHHHHHHHHHHHHHH | 7.50 | 29967540 | |
| 164 | Ubiquitination | VYQALQKSNGVLPEL HHHHHHHCCCCCCHH | 26.34 | 29967540 | |
| 174 | Ubiquitination | VLPELFQCHGTADEL CCCHHHCCCCCHHHH | 2.21 | 21890473 | |
| 177 | Ubiquitination | ELFQCHGTADELVLH HHHCCCCCHHHHHHH | 13.79 | 21890473 | |
| 186 | Ubiquitination | DELVLHSWAEETNSM HHHHHHHHHHHHHHH | 9.28 | 29967540 | |
| 190 | Ubiquitination | LHSWAEETNSMLKSL HHHHHHHHHHHHHHC | 24.89 | 21890473 | |
| 199 | Ubiquitination | SMLKSLGVTTKFHSF HHHHHCCCCCCCCCC | 8.13 | 21890473 | |
| 202 | Ubiquitination | KSLGVTTKFHSFPNV HHCCCCCCCCCCCCH | 31.54 | 29967540 | |
| 202 | Acetylation | KSLGVTTKFHSFPNV HHCCCCCCCCCCCCH | 31.54 | 25953088 | |
| 202 | Malonylation | KSLGVTTKFHSFPNV HHCCCCCCCCCCCCH | 31.54 | 30639696 | |
| 212 (in isoform 2) | Ubiquitination | - | 36.73 | 21890473 | |
| 212 | Ubiquitination | SFPNVYHELSKTELD CCCCHHHHCCHHHHH | 36.73 | 21890473 | |
| 214 | Phosphorylation | PNVYHELSKTELDIL CCHHHHCCHHHHHHH | 34.25 | 29083192 | |
| 221 | Ubiquitination | SKTELDILKLWILTK CHHHHHHHHHHHHHC | 3.58 | 21890473 | |
| 228 | Ubiquitination | LKLWILTKLPGEMEK HHHHHHHCCCCHHHH | 49.60 | 21890473 | |
| 228 (in isoform 1) | Ubiquitination | - | 49.60 | 21890473 | |
| 228 | Ubiquitination | LKLWILTKLPGEMEK HHHHHHHCCCCHHHH | 49.60 | 21890473 | |
| 235 | Ubiquitination | KLPGEMEKQK----- CCCCHHHHCC----- | 63.18 | - | |
| 237 | Ubiquitination | PGEMEKQK------- CCHHHHCC------- | 73.67 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LYPL1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYPL1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYPL1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of LYPL1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |